MARKETS
Earnings

Tenet Healthcare Raises FY2026 Adj EPS Guidance from $16.38-$18.68 to $20.30-$21.69 vs $17.88 Est; Raises FY2026 Sales Guidance from $21.500B-$22.300B to $21.900B-$22.500B vs $21.996B Est

Jul 23, 2026 · 04:40 PM ET· updated 2h ago

Tenet Healthcare (NYSE:THC) raises FY2026 Adj EPS guidance from $16.38-$18.68 to $20.30-$21.69 vs $17.88 analyst estimate. Raises FY2026 sales outlook from $21.500 billion-$22.300 billion to $21.900 billion-$22.500

Share
Why It Matters

Tenet Healthcare thinks it will make much more money next year than it said before—both from selling more services and from running more efficiently. When a big company raises its promises like this, it usually means business is going better than expected, which is worth noticing.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.